SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Howard Hughes Synthetic CCD

PatientHoward Hughes
Date of birth1984-12-24
IdentifiersMRN HR-ML006-SYN; SSN (made up) 000-06-5571
Document date2026-11-01
AuthorAnselm Garrity-Moyo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care ten months after a plane crash: contamination fears with washing and avoidance, chronic pain on long-term codeine, an opioid review, hearing, weight, kidney health and safety. Concerns: He wants to get back to full days of work without hours of washing and checking, and without other people seeing his rituals; He is afraid that without codeine the pain from the crash will stop him working; He wants his privacy protected and nothing about his care known outside the clinic. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 300 mg with codeine 30 mg oral tablet, prescribed elsewhere since the crash as one or two tablets every 6 hours as needed, no more than 8 a day; he has been taking 10 to 12 a dayOne or two tablets every 6 hours as needed, no more than 8 a dayOral route2026-05-04 to 2026-05-11completedS
Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with instruction for him and his household staffOne spray as needed for suspected overdose; repeat in 2 to 3 minutes if neededNasal route2026-05-04activeS
Buprenorphine 2 mg with naloxone 0.5 mg sublingual film for the first day: 4 mg once withdrawal is moderate (COWS 12 or more), then 2 to 4 mg every one to two hours as needed, to no more than 16 mg on the first dayFirst-day induction by the written plan, no more than 16 mgSublingual route2026-05-11 to 2026-05-12completedS
Buprenorphine 8 mg with naloxone 2 mg sublingual film, one film twice daily (16 mg a day), for opioid use disorder and pain; dispensed one week at a time at firstOne film under the tongue twice dailySublingual route2026-05-12activeS
Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain after the crash, now that codeine combination tablets have stoppedTwo tablets three times daily, no more than 3,000 mg a dayOral route2026-05-11activeS
Sertraline 50 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-05-11 to 2026-06-08completedS
Sertraline 100 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-06-08 to 2026-07-13completedS
Sertraline 100 mg oral tablet, two tablets daily (200 mg), the usual target range for OCDTwo tablets dailyOral route2026-07-13activeS

Procedures

ProcedureDatesStatusEvidence
Pure-tone audiometry: bilateral high-frequency sensorineural hearing loss with a notch at 4000 Hz; speech discrimination good in quiet2026-06-08 to 2026-06-08completedS
Hearing aid fitting: bilateral behind-the-ear hearing aids with a remote microphone for meetings2026-07-13 to 2026-07-13completedS
Advance care planning conversation, about 16 minutes2026-09-14 to 2026-09-14completedS

Immunizations

DateVaccineStatusEvidence
2026-09-14Influenza vaccine for the coming seasoncompletedS
2026-09-14Tdap vaccine; no tetanus booster recorded since the crashcompletedS
2026-09-14Hepatitis B vaccine (HepB-CpG), first of two doses; not immune at intakecompletedS
2026-10-05COVID-19 vaccine for the coming seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1919Paralysis as a boy for which no cause was found, after which he developed a lasting fear for his healthD (CLM-0003)
1944A nervous breakdown, recorded without detailD (CLM-0004)
July 7, 1946Critical injuries in a plane crash: crushed chest, collapsed lung, multiple fractures and burns; pain and codeine sinceD (CLM-0005, CLM-0006)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He wants to get back to full days of work without hours of washing and checking, and without other people seeing his ritualsactiveS
He is afraid that without codeine the pain from the crash will stop him workingactiveS
He wants his privacy protected and nothing about his care known outside the clinicactiveS

Assessment

Most recent measures: Leukocytes [#/volume] in Blood by Automated count 6.4 on 2026-05-04; Hemoglobin [Mass/volume] in Blood 14.1 on 2026-05-04; MCV [Entitic mean volume] in Red Blood Cells by Automated count 91 on 2026-05-04; Platelets [#/volume] in Blood by Automated count 248 on 2026-05-04; Sodium [Moles/volume] in Serum or Plasma 140 on 2026-10-05; Potassium [Moles/volume] in Serum or Plasma 4.3 on 2026-10-05; Creatinine [Mass/volume] in Serum or Plasma 0.96 on 2026-10-05; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 102 on 2026-10-05; Glucose [Mass/volume] in Serum or Plasma 86 on 2026-10-05; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 2026-10-05; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27 on 2026-10-05; Albumin [Mass/volume] in Serum or Plasma 4.2 on 2026-10-05; Thyrotropin [Units/volume] in Serum or Plasma 1.6 on 2026-05-04; Albumin/Creatinine [Mass Ratio] in Urine 8 on 2026-05-04; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 2026-10-05; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 6 on 2026-10-05; Total score [DAST-10] 5 on 2026-05-04; Total score [AUDIT-C] 1 on 2026-05-04; Mean score [PEG] 4 on 2026-10-05; PTSD PCL-5 score [PCL-5] 18 on 2026-05-11; Hearing threshold Ear - right --500 Hz 20 on 2026-06-08; Hearing threshold Ear - left --500 Hz 20 on 2026-06-08; Hearing threshold Ear - right --1000 Hz 25 on 2026-06-08; Hearing threshold Ear - left --1000 Hz 30 on 2026-06-08; Hearing threshold Ear - right --2000 Hz 35 on 2026-06-08; Hearing threshold Ear - left --2000 Hz 40 on 2026-06-08; Hearing threshold Ear - right --4000 Hz 60 on 2026-06-08; Hearing threshold Ear - left --4000 Hz 65 on 2026-06-08; Cholesterol [Mass/volume] in Serum or Plasma 182 on 2026-09-14; Cholesterol in HDL [Mass/volume] in Serum or Plasma 52 on 2026-09-14; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 112 on 2026-09-14; Triglyceride [Mass/volume] in Serum or Plasma 90 on 2026-09-14; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-09-14 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Intrusive fears of contamination by germs for about a year, worse since the crash, with hand washing, cleaning of objects and avoidance of handshakes, shared spaces and food handled by others, taking about four hours a day; he recognizes the fears are probably excessive; cause under evaluationresolvedconfirmed R46.81S — Synthetic presenting problem anchored to his documented fear of germs; resolved into the diagnosis of OCD at the consultation. Not a claim about his real symptoms in 1947.
Obsessive-compulsive disorder, contamination type, with good or fair insight, not tic-related; Y-BOCS 28 (severe) at intake; no post-traumatic stress disorder on screeningactiveconfirmed F42.2S — Synthetic modern diagnosis made at the consultation, linked to the retrospective interpretation of his documented fears (R). Not a claim about his real diagnosis.
Opioid use disorder, moderate (four of the DSM-5-TR criteria that count for a prescribed opioid: taking more than prescribed, failed attempts to cut down, time spent getting prescriptions from two prescribers, and craving), on codeine prescribed after a crash; buprenorphine plannedactiveconfirmed F11.20S — Synthetic modern coding; tolerance and withdrawal are not counted for a medicine taken under medical supervision. Person-first language; not a claim about his real diagnosis.
Chronic pain after major trauma ten months ago (crushed chest with rib fractures, collapsed lung, other fractures and burns): chest wall, left shoulder and low back pain, PEG 6.7activeconfirmed G89.21S — Synthetic modern diagnosis anchored to his documented injuries.
Difficulty hearing conversation, worse in noise, after years of flying in loud aircraft; cause under evaluationresolvedconfirmed H91.93S — Synthetic presenting problem; resolved into a diagnosis when audiometry was done at five weeks. His documented deafness is from later years.
Bilateral high-frequency sensorineural hearing loss with a notch at 4000 Hz, consistent with noise exposure from flying; hearing aids fittedactiveconfirmed H90.3S — Synthetic modern diagnosis made at five weeks; not a claim about his real hearing in 1947.
Weight loss of about 8 kg since the crash (BMI 19.7), from eating little outside food he has prepared or inspected himself because of contamination fearsactiveconfirmed R63.4S — Synthetic nutrition problem linked to the contamination fears; not a claim about his real weight in 1947.
Acute bronchitis, likely viral, for five days; no pneumonia on examination; resolved within three weeks without antibioticsresolvedconfirmed J20.9S — Synthetic acute illness; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-04Leukocytes [#/volume] in Blood by Automated count6.410*3/uL4-11 10*3/uLNormalS
2026-05-04Hemoglobin [Mass/volume] in Blood14.1g/dL13.5-17.5 g/dLNormalS
2026-05-04MCV [Entitic mean volume] in Red Blood Cells by Automated count91fL80-100 fLNormalS
2026-05-04Platelets [#/volume] in Blood by Automated count24810*3/uL150-400 10*3/uLNormalS
2026-05-04Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-05-04Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-05-04Creatinine [Mass/volume] in Serum or Plasma0.94mg/dL0.74-1.35 mg/dLNormalS
2026-05-04Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M104mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-05-04Glucose [Mass/volume] in Serum or Plasma84mg/dL70-99 mg/dLNormalS
2026-05-04Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L10-40 U/LNormalS
2026-05-04Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma38U/L7-56 U/LNormalS
2026-05-04Albumin [Mass/volume] in Serum or Plasma3.7g/dL3.5-5 g/dLNormalS
2026-05-04Thyrotropin [Units/volume] in Serum or Plasma1.6m[IU]/L0.4-4.5 mIU/LNormalS
2026-05-04Albumin/Creatinine [Mass Ratio] in Urine8mg/g{creat}<=29 mg/g{creat}NormalS
2026-05-04Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
2026-05-04Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]12{score}S
2026-05-04Total score [DAST-10]5{score}S
2026-05-04Total score [AUDIT-C]1{score}S
2026-05-04Mean score [PEG]6.7{score}S
2026-05-11PTSD PCL-5 score [PCL-5]18{score}S
2026-06-08Hearing threshold Ear - right --500 Hz20dB25 dB HL or better is normal hearingNormalS
2026-06-08Hearing threshold Ear - left --500 Hz20dB25 dB HL or better is normal hearingNormalS
2026-06-08Hearing threshold Ear - right --1000 Hz25dB25 dB HL or better is normal hearingNormalS
2026-06-08Hearing threshold Ear - left --1000 Hz30dB25 dB HL or better is normal hearingHighS
2026-06-08Hearing threshold Ear - right --2000 Hz35dB25 dB HL or better is normal hearingHighS
2026-06-08Hearing threshold Ear - left --2000 Hz40dB25 dB HL or better is normal hearingHighS
2026-06-08Hearing threshold Ear - right --4000 Hz60dB25 dB HL or better is normal hearingHighS
2026-06-08Hearing threshold Ear - left --4000 Hz65dB25 dB HL or better is normal hearingHighS
2026-06-08Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
2026-06-08Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]10{score}S
2026-06-08Mean score [PEG]5.7{score}S
2026-07-13Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-07-13Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]8{score}S
2026-07-13Mean score [PEG]4.7{score}S
2026-10-05Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-10-05Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-10-05Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.74-1.35 mg/dLNormalS
2026-10-05Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M102mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-10-05Glucose [Mass/volume] in Serum or Plasma86mg/dL70-99 mg/dLNormalS
2026-10-05Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L10-40 U/LNormalS
2026-10-05Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma27U/L7-56 U/LNormalS
2026-10-05Albumin [Mass/volume] in Serum or Plasma4.2g/dL3.5-5 g/dLNormalS
2026-10-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-10-05Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]6{score}S
2026-10-05Mean score [PEG]4{score}S
2026-09-14Cholesterol [Mass/volume] in Serum or Plasma182mg/dL<=199 mg/dLNormalS
2026-09-14Cholesterol in HDL [Mass/volume] in Serum or Plasma52mg/dL>=40 mg/dLNormalS
2026-09-14Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation112mg/dL<=129 mg/dLNormalS
2026-09-14Triglyceride [Mass/volume] in Serum or Plasma90mg/dL<=149 mg/dLNormalS
2026-09-14Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-05-04Body height191cmS
2026-05-04Body weight72kgS
2026-05-04Body mass index (BMI) [Ratio]19.7kg/m2S
2026-05-04Systolic blood pressure122mm[Hg]S
2026-05-04Diastolic blood pressure78mm[Hg]S
2026-05-04Heart rate92/minS
2026-05-04Respiratory rate16/minS
2026-05-04Body temperature36.7CelS
2026-05-04Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-05-11Body height191cmS
2026-05-11Body weight72.3kgS
2026-05-11Body mass index (BMI) [Ratio]19.8kg/m2S
2026-05-11Systolic blood pressure124mm[Hg]S
2026-05-11Diastolic blood pressure80mm[Hg]S
2026-05-11Heart rate88/minS
2026-05-11Respiratory rate16/minS
2026-05-11Body temperature36.8CelS
2026-05-11Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-06-08Body height191cmS
2026-06-08Body weight73.4kgS
2026-06-08Body mass index (BMI) [Ratio]20.1kg/m2S
2026-06-08Systolic blood pressure118mm[Hg]S
2026-06-08Diastolic blood pressure76mm[Hg]S
2026-06-08Heart rate78/minS
2026-06-08Respiratory rate14/minS
2026-06-08Body temperature36.6CelS
2026-06-08Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-07-13Body height191cmS
2026-07-13Body weight74.6kgS
2026-07-13Body mass index (BMI) [Ratio]20.4kg/m2S
2026-07-13Systolic blood pressure116mm[Hg]S
2026-07-13Diastolic blood pressure74mm[Hg]S
2026-07-13Heart rate74/minS
2026-07-13Respiratory rate14/minS
2026-07-13Body temperature36.7CelS
2026-07-13Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-05Body height191cmS
2026-10-05Body weight76.2kgS
2026-10-05Body mass index (BMI) [Ratio]20.9kg/m2S
2026-10-05Systolic blood pressure118mm[Hg]S
2026-10-05Diastolic blood pressure76mm[Hg]S
2026-10-05Heart rate72/minS
2026-10-05Respiratory rate14/minS
2026-10-05Body temperature36.6CelS
2026-10-05Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-09-14Body height191cmS
2026-09-14Body weight75.6kgS
2026-09-14Body mass index (BMI) [Ratio]20.7kg/m2S
2026-09-14Systolic blood pressure116mm[Hg]S
2026-09-14Diastolic blood pressure74mm[Hg]S
2026-09-14Heart rate70/minS
2026-09-14Respiratory rate14/minS
2026-09-14Body temperature36.6CelS
2026-09-14Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-06-22Body height191cmS
2026-06-22Body weight73.6kgS
2026-06-22Body mass index (BMI) [Ratio]20.2kg/m2S
2026-06-22Systolic blood pressure120mm[Hg]S
2026-06-22Diastolic blood pressure76mm[Hg]S
2026-06-22Heart rate84/minS
2026-06-22Respiratory rate18/minS
2026-06-22Body temperature37.4CelS
2026-06-22Oxygen saturation in Arterial blood by Pulse oximetry97%S

Encounters

DatePurposeStatusProvenance
2026-05-04Establishing primary care ten months after a plane crash: contamination fears with washing and avoidance, chronic pain on long-term codeine, an opioid review, hearing, weight, kidney health and safetyfinishedS
2026-05-11One-week review, seen the same day by psychiatry: the diagnosis of OCD, an SSRI, exposure and response prevention, and starting buprenorphinefinishedS
2026-06-08Five-week review: OCD treatment, buprenorphine, pain, the audiogram and weightfinishedS
2026-07-13Ten-week review: sertraline to an OCD dose, exposure therapy and his staff's part in it, hearing aids and painfinishedS
2026-10-05Twenty-two-week review: response of OCD, buprenorphine maintenance, pain, weight and laboratory checksfinishedS
2026-09-14Periodic adult preventive visitfinishedS
2026-06-22Same-day sick visit for a coughfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Psychiatry consultation to confirm the diagnosis, advise on an SSRI at OCD doses with buprenorphine, plan exposure and response prevention, and advise on how his staff can stop carrying out rituals for himcompletedGL-APA-OCD-2007, GL-APA-OCD-WATCH-2013, GL-NICE-CG31S
Opioid review under the CDC 2022 guideline: benefits and harms reviewed with him, a prescription drug monitoring program check before every controlled-substance prescription, urine drug testing with consent and explained as part of care, one prescriber and one pharmacy, a nonjudgmental DSM-5-TR assessment for opioid use disorder, and no abrupt stop of codeinecompletedGL-CDC-OPIOID-2022, GL-CDC-PDMPS
Buprenorphine with naloxone for opioid use disorder and pain: induction in the clinic at one week after about 20 hours without codeine, then 8 mg twice daily, dispensed weekly at first; naloxone nasal spray at home; no benzodiazepines; leftover codeine to a pharmacy take-backcompletedGL-CDC-OPIOID-2022, GL-ASAM-OUD-2020S
Pain after major trauma: scheduled acetaminophen up to 3,000 mg a day, physical therapy for the chest wall, left shoulder and low back, graded activity, sleep, and pain coping skills woven into his therapy; no NSAID long termcompletedGL-CDC-OPIOID-2022S
OCD treatment: exposure and response prevention with a psychologist, weekly 90-minute sessions with home practice, then twice weekly; sertraline from 50 mg, raised every four to six weeks as tolerated toward 200 mg; response judged by the Y-BOCS at each visit; augmentation with a low-dose antipsychotic (aripiprazole or risperidone) or a switch to clomipramine considered only if the response is poor after 8 to 12 weeks at the highest tolerated dosecompletedGL-APA-OCD-2007, GL-APA-OCD-WATCH-2013, GL-NICE-CG31S
Accommodation by staff: with his written consent, his assistant joins two therapy sessions; staff stop carrying out rituals for him in planned steps that follow his exposure hierarchy, offer support instead of reassurance, and are not asked to report on himcompletedGL-APA-OCD-2007, GL-NICE-CG31S
Safety: a structured safety assessment, a written safety plan, the 988 Suicide & Crisis Lifeline in his phone, means safety for opioids, and safety review at every visitcompletedGL-SUICIDE-2024, GL-CMID-2026S
Hearing: audiometry, then hearing aids and a remote microphone if hearing loss is confirmed; hearing protection when flying and in the factorycompletedGL-NICE-NG98S
Nutrition and weight: a dietitian visit, three meals a day built into his exposure plan (food made by his cook, then food from a restaurant), weight at each visit, albumin at baseline and follow-up; no supplements neededcompletedGL-APA-OCD-2007S
Kidney health: creatinine, eGFR and urine albumin at baseline and a metabolic panel at follow-up while on scheduled acetaminophen and any new medicine; acetaminophen kept at or below 3,000 mg a day; no long-term NSAIDcompletedGL-CDC-OPIOID-2022S
Privacy: care documented in the clinic record only; letters about his health go only to people he namescompletedGL-APA-OCD-2007S

Goals

GoalTargetStatusOutcomeProvenance
Y-BOCS down by at least 35 percent (response) within six months2026-10-05completedY-BOCS 28 at intake, 14 at twenty-two weeks (a 50 percent fall); washing and checking about one hour a dayS
Stop codeine and stay on buprenorphine with no use of other opioids2026-10-05completedCodeine stopped at one week; all urine tests positive for buprenorphine and negative for other opioidsS
Pain that lets him work and sleep: PEG at or below 42026-10-05activePEG 6.7 at intake to 4.0 at twenty-two weeksS
Regain weight to at least 76 kg with regular meals2026-10-05completed72.0 kg at intake to 76.2 kg; three meals a day, including food prepared by his cookS
Follow conversation in meetings with hearing aids2026-10-05completedHearing aids fitted at ten weeks and worn every dayS
Staff stop carrying out rituals for him, step by step, by his own plan2026-10-05activeTissue-wrapping and the hand-washing rule for staff stopped; food preparation rules relaxed; visitors no longer screened for illnessS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-05-04: current ideation absent, intent absent, plan absent. Outpatient care with weekly visits at first. Risk factors reviewed without detail: a breakdown in earlier years, opioid use disorder, chronic pain, severe OCD, isolation and anxiety. No current thoughts of suicide. Opioids are dangerous in overdose, so means safety is part of the plan: naloxone nasal spray at home with his staff taught to use it, unused codeine tablets taken to a pharmacy take-back, and buprenorphine dispensed one week at a time at first. A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in his phone. Safety is reviewed at every visit [S]